Related Experiment Video
Updated: Jun 25, 2026

Development of an IFN-γ ELISpot Assay to Assess Varicella-Zoster Virus-specific Cell-mediated Immunity Following Umbilical Cord Blood Transplantation
Published on: July 9, 2014
[Post-varicella purpura fulminans: potentially fatal]
A Hernández Blanco1, R González Montero, M M Urán Moreno
1Servicio de Pediatría, Hospital Universitario San Juan, Alicante, España. aida12@gmail.com
Abstract:
Although varicella is usually a benign disease, some of its complications, such as post-varicella purpura fulminans, can be fatal. Its pathophysiological mechanism is caused by the production of antibodies to protein C and protein S in the coagulation cascade. This could have fatal consequences for those patients with partial deficiency of these proteins that develop disseminated intravascular coagulation. Treatment is symptomatic: fresh frozen plasma to treat protein depletion, antithrombin III and heparinization against thrombus formation, and anti-inflammatory drugs (steroids). However, new therapies, such as prostaglandin E1 IV and prostacyclin, are being introduced.
Related Concept Videos
Chickenpox
Rocky Mountain Spotted Fever
Smallpox
Endocarditis II: Clinical Features of Infective Endocarditis
Yellow Fever
Cytotoxic Edema: Pathophysiology
